These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25345941)

  • 1. [Effect of Biejiajian Pills on Wnt signal pathway molecules β-catenin and GSK-3β and the target genes CD44v6 and VEGF in hepatocellular carcinoma cells].
    Sun H; He S; Wen B; Jia W; Fan E; Zheng Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Oct; 34(10):1454-8. PubMed ID: 25345941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Biejiajian Pills on Wnt/β-catenin signal pathway and DKK-1 and FrpHe gene expressions in hepatocellular carcinoma cells].
    He S; Cheng Y; Zhu Y; Fan Q; Sun H; Jia W
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):30-3. PubMed ID: 23353151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Biejiajian Pills on Wnt signal pathway signal molecules β-catenin/TCF4 complex activities and downstream proteins cyclin D1 and MMP-2 in hepatocellular carcinoma cells].
    Wen B; Sun H; He S; Cheng Y; Jia W; Fan E; Pang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1758-62. PubMed ID: 25537897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of Biejiajian pills on HepG2 cell xenograft growth and expression of β-catenin and Tbx3 in nude mice].
    Wen B; Sun HT; He SQ; LA L; An HY; Pang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):210-4. PubMed ID: 26922018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    An H; Lin J; Sun H; Xu L; Su J; He C; Zeng J; Liang P; He S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):997-1001. PubMed ID: 30187871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role and significance of Wnt/beta-catenin signaling pathway regulating the signaling molecules in hepatocellular carcinoma].
    Wang XH; Sun X; Meng XW; Lü ZW; Liu MN; Pei FH
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):672-5. PubMed ID: 20943078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 and beta-catenin signaling pathway may affect GSK-3beta expression in hepatocellular carcinoma.
    Wang XH; Meng XW; Xing H; Qu B; Han MZ; Chen J; Fan YJ; Lu CQ; Lu ZW
    Hepatogastroenterology; 2011; 58(106):487-91. PubMed ID: 21661417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.
    Zhang L; Tu Y; He W; Peng Y; Qiu Z
    Eur J Pharmacol; 2015 Sep; 762():55-62. PubMed ID: 26004524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
    Fan W; Du F; Liu X
    Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
    Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
    Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
    Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
    Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice.
    Wu HC; Lay IS; Shibu MA; Ho TJ; Cheng SM; Lin CH; Dung TD; Jeng LB; Viswanadha VP; Huang CY
    Environ Toxicol; 2017 Sep; 32(9):2133-2143. PubMed ID: 28548306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
    Cui J; Zhou X; Liu Y; Tang Z; Romeih M
    Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma.
    Ban KC; Singh H; Krishnan R; Seow HF
    Cancer Lett; 2003 Sep; 199(2):201-8. PubMed ID: 12969793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3β/Wnt/β-catenin signalling.
    Li W; Xue H; Li Y; Li P; Ma F; Liu M; Kong S
    Clin Exp Pharmacol Physiol; 2019 Sep; 46(9):845-853. PubMed ID: 31168819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Gai JQ; Sheng X; Qin JM; Sun K; Zhao W; Ni L
    Int J Oncol; 2016 Jan; 48(1):338-48. PubMed ID: 26648168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.